CEACAM5 and colorectal cancer: A number of studies have attempted to detect colorectal cancer lesions using fluorescently labeled antibodies against surface markers such as epidermal growth factor receptor (EGFR), CEA, or vascular endothelial growth factor (VEGF)27–29.